D.E. Shaw & Co
OPTR

D.E. Shaw & Co’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

D.E. Shaw & Co’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-349,857
Closed -$4.41M – 4921
2013
Q3 		$4.41M Buy
349,857
+164,926
+89% +$2.19M 0.01% 1716
2013
Q2 		$2.68M Buy
+184,931
New +$2.69M 0.01% 1854

D.E. Shaw & Co's OPTR Position: Q4 2013 in Review

D.E. Shaw & Co sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 349,857 shares — an estimated $4.41M sold.

D.E. Shaw & Co first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $4.41M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • D.E. Shaw & Co reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • D.E. Shaw & Co sold 349,857 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $4.41M.
  • D.E. Shaw & Co first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • D.E. Shaw & Co's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $4.41M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.